Blackstone (BX) Explores $2 Billion Sale of ZO Skin Health

Blackstone Inc. (NYSE: BX) is considering a sale of ZO Skin Health, which may be valued at approximately $2 billion. This potential sale is in early stages, with Blackstone collaborating with Citigroup and Raymond James. The interest stems from a growing demand for clinically positioned skincare brands that are sold through professionals, offering a premium image. A successful sale could not only provide significant cash for Blackstone but also indicate strength in its consumer healthcare strategy, benefiting investors as it demonstrates effective business growth and value realization.